Novanta (NOVT)

• Market cap: $5.61B
• 1 day: 0.35%
• 5 days: -0.67%
• 1 month: -6.31%
• 3 months: -12.44%
• 6 months: -2.73%
• Year to date: -4.98%
• 1 year: -8.85%
• 5 years: 71.32%
• 10 years: 942.82%
• Sector: Industrials
• Industry: Miscellaneous Electrical Machinery, Equipment & Supplies

About: Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.

Employees: 2,900

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

62% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 26

14% more repeat investments, than reductions

Existing positions increased: 104 | Existing positions reduced: 91

9% more capital invested

Capital invested by funds: $5.72B [Q2] → $6.25B (+$534M) [Q3]

6% more funds holding

Funds holding: 268 [Q2] → 284 (+16) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q2] → 2 (+0) [Q3]

0.32% less ownership

Funds ownership: 97.71% [Q2] → 97.39% (-0.32%) [Q3]

55% less call options, than puts

Call options by funds: $6.07M | Put options by funds: $13.5M

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $169 8% upside
• Avg. target: $169 8% upside
• High target: $169 8% upside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

Baird Robert Mason 46% 1-year accuracy 6 / 13 met price target

8% upside $169

Neutral Maintained

6 Nov 2024